Clinical trial
PROMISE Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of an Implantable Continuous Glucose Sensor Lasting up to 180 Days
NCT03808376 is registered in ClinicalTrials.gov with Senseonics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROMISE Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of an Implantable Continuous Glucose Sensor Lasting up to 180 Days
- Lead sponsor
- Senseonics, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 27, 2018
- Completion date
- May 8, 2020
- Enrollment
- 208 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.